Physician profile
Hamza Rana
NPI 1194745489
$6,102.29
in general payments reported to CMS, 2019-2025
49 companies · $513 in 2025
The $513 reported for 2025 was more than what 78% of Phlebology providers received nationally (typical 2025 total: $141).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $898 · 2020: $1,191 · 2021: $1,040 · 2022: $377 · 2023: $1,014 · 2024: $1,069 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,358 · Long Term Medical Supply Or Device Loan: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,357.75 |
| Long Term Medical Supply Or Device Loan | $238.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $1,104.61 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Amgen INC. | $520.17 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $448.77 | 2019-2023 | Xarelto |
| Pfizer INC. | $345.93 | 2019-2025 | |
| Integra Lifesciences Corporation | $263.21 | 2024 | Acell, Integra, Integra Dermal Regeneration Template |
| Astrazeneca Pharmaceuticals Lp | $247.00 | 2019-2024 | Farxiga |
| Medtronic, INC. | $229.82 | 2021-2023 | Closurefast |
| Esperion Therapeutics, INC. | $214.69 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $214.47 | 2022-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.19 | 2019-2023 | Jardiance |
| Amarin Pharma, INC. | $182.55 | 2020-2022 | |
| Smith+Nephew, INC. | $151.04 | 2021-2025 | Collagenase Santyl |
| E.R. Squibb & Sons, L.L.C. | $140.92 | 2023-2024 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $139.62 | 2019-2024 | |
| Medtronic Vascular, INC. | $131.77 | 2020 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocompatibles, INC. | $117.87 | 2019 | |
| Boston Scientific Corporation | $115.46 | 2021-2025 | Watchman Flx, Varithena Administration Pack |
| Irhythm Technologies, INC. | $102.54 | 2024 | Zio Monitor, Zio Xt Patch |
| Cashflow Solutions, LLC | $97.61 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Kestra Medical Technology Services, INC. | $95.93 | 2023-2025 | Assure Wcd |
| Kerecis Limited | $88.22 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbott Laboratories | $77.32 | 2019 | |
| Novo Nordisk INC | $76.61 | 2021-2024 | Ozempic |
| Abbvie INC. | $62.34 | 2021-2023 | |
| Progenacare Global, LLC | $60.01 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $58.92 | 2024 | Arcalyst |
| Baxter Healthcare | $58.23 | 2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Bard Peripheral Vascular, INC. | $52.22 | 2024 | Venclose Maven Catheter |
| Hartmann USA, INC. | $46.19 | 2021-2023 | Zetuvit Plus |
| Bridgebio Pharma, INC. | $42.99 | 2025 | Attruby |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.38 | 2021 | |
| Next Science LLC | $41.31 | 2023 | Surgx, Blastx, Xperience |
| Kiniksa Pharmaceuticals, Ltd. | $40.02 | 2022-2023 | Arcalyst |
| Convatec INC. | $36.82 | 2021-2022 | |
| Glaxosmithkline, LLC. | $25.85 | 2025 | Shingrix |
| Scpharmaceuticals INC. | $22.84 | 2024 | |
| Amryt Pharma Holdings Ltd | $20.41 | 2021 | |
| Vital Connect, INC | $20.26 | 2023 | Vitalpatch Rtm |
| Bayer Healthcare Pharmaceuticals INC. | $19.26 | 2024 | |
| Heartflow, INC. | $19.07 | 2025 | |
| Hydrofera LLC | $18.34 | 2023 | Hydrofera Blue |
| Astellas Pharma US INC | $18.16 | 2021 | |
| Solventum Corporation | $17.40 | 2025 | Activ.A.C. |
| Mimedx Group, INC. | $17.31 | 2025 | |
| Ovik Health, LLC | $14.76 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $13.97 | 2023 | Inpefa |
| Ge Healthcare | $13.81 | 2025 | |
| United Therapeutics Corporation | $12.78 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamza Rana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.